PCN166 - Cost Minimization Analysis of Bevacizumab Versus Cetuximab and Panitumumab in the Management of Colorectal Cancer from Patient Perspective in Egypt
| Autor: | Ragab, MF, Assal, RA, Abdelrahman, MM, Elsisi, G |
|---|---|
| Zdroj: | In Value in Health November 2016 19(7):A738-A738 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect